http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010500565-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2007-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010500565-A |
| titleOfInvention | Methods for identifying, evaluating, and treating patients with cancer treatments |
| abstract | The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are expected to exhibit long or short survival. In particular, the present invention is directed to the use of certain individual predictive markers and / or combinations of predictive markers, where expression of the predictive marker correlates with expected short-term or long-term survival. Therefore, it is possible to determine the predicted patient survival by examining the expression level of predictive markers, including individual predictive markers and / or marker sets. |
| priorityDate | 2006-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.